Stanley S. Ng

2.3k total citations
19 papers, 1.5k citations indexed

About

Stanley S. Ng is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stanley S. Ng has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stanley S. Ng's work include Epigenetics and DNA Methylation (11 papers), Histone Deacetylase Inhibitors Research (8 papers) and Cancer-related gene regulation (7 papers). Stanley S. Ng is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), Histone Deacetylase Inhibitors Research (8 papers) and Cancer-related gene regulation (7 papers). Stanley S. Ng collaborates with scholars based in United Kingdom, United States and Singapore. Stanley S. Ng's co-authors include Udo Oppermann, Christopher J. Schofield, Nathan R. Rose, M.A. McDonough, Wyatt W. Yue, Robert J. Klose, Benoît M. R. Liénard, Jasmin Mecinović, James E. Bray and K.L. Kavanagh and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Stanley S. Ng

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley S. Ng United Kingdom 14 1.3k 171 91 84 83 19 1.5k
Louise J. Walport United Kingdom 17 1.2k 0.9× 185 1.1× 103 1.1× 57 0.7× 93 1.1× 36 1.4k
Rok Sekirnik United Kingdom 15 628 0.5× 288 1.7× 36 0.4× 54 0.6× 110 1.3× 27 792
Debin Ji United States 15 927 0.7× 201 1.2× 58 0.6× 16 0.2× 58 0.7× 40 1.1k
Jordi Frigola Spain 16 1.2k 0.9× 200 1.2× 142 1.6× 25 0.3× 251 3.0× 42 1.6k
Herschel Wade United States 13 829 0.6× 41 0.2× 107 1.2× 96 1.1× 90 1.1× 24 1.0k
Sreenivas Kanugula United States 24 1.0k 0.8× 281 1.6× 158 1.7× 11 0.1× 151 1.8× 37 1.2k
Ganesh Nagaraju India 22 1.1k 0.8× 206 1.2× 459 5.0× 59 0.7× 171 2.1× 36 1.5k
Karina Goodtzova United States 13 485 0.4× 121 0.7× 98 1.1× 78 0.9× 65 0.8× 14 576
Nobuko Shindo‐Okada Japan 16 870 0.7× 75 0.4× 118 1.3× 13 0.2× 75 0.9× 36 980
Zhifeng Yu United States 22 944 0.7× 380 2.2× 50 0.5× 23 0.3× 299 3.6× 41 1.5k

Countries citing papers authored by Stanley S. Ng

Since Specialization
Citations

This map shows the geographic impact of Stanley S. Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley S. Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley S. Ng more than expected).

Fields of papers citing papers by Stanley S. Ng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley S. Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley S. Ng. The network helps show where Stanley S. Ng may publish in the future.

Co-authorship network of co-authors of Stanley S. Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley S. Ng. A scholar is included among the top collaborators of Stanley S. Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley S. Ng. Stanley S. Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lu, Dan, et al.. (2020). 573 A novel human anti-PD1/IL15 bi-functional protein with robust anti-tumor activity and low systemic toxicity. SHILAP Revista de lepidopterología. A344.2–A344. 1 indexed citations
2.
Zhao, Qing, Stanley S. Ng, & Heather J. Kulik. (2016). Predicting the Stability of Fullerene Allotropes Throughout the Periodic Table. The Journal of Physical Chemistry C. 120(30). 17035–17045. 7 indexed citations
3.
Chowdhury, Rasheduzzaman, Rok Sekirnik, Nigel C. Brissett, et al.. (2014). Ribosomal oxygenases are structurally conserved from prokaryotes to humans. Nature. 510(7505). 422–426. 88 indexed citations
4.
England, Katherine S., Anthony Tumber, T. Krojer, et al.. (2014). Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. MedChemComm. 5(12). 1879–1886. 24 indexed citations
5.
6.
Woon, Esther C. Y., Anthony Tumber, Akane Kawamura, et al.. (2012). Linking of 2‐Oxoglutarate and Substrate Binding Sites Enables Potent and Highly Selective Inhibition of JmjC Histone Demethylases. Angewandte Chemie International Edition. 51(7). 1631–1634. 55 indexed citations
7.
Woon, Esther C. Y., Anthony Tumber, Akane Kawamura, et al.. (2012). Linking of 2‐Oxoglutarate and Substrate Binding Sites Enables Potent and Highly Selective Inhibition of JmjC Histone Demethylases. Angewandte Chemie. 124(7). 1663–1666. 9 indexed citations
8.
Zhang, Zhihong, Grazyna Kochan, Stanley S. Ng, et al.. (2011). Crystal structure of PHYHD1A, a 2OG oxygenase related to phytanoyl-CoA hydroxylase. Biochemical and Biophysical Research Communications. 408(4). 553–558. 20 indexed citations
9.
Hillringhaus, Lars, Wyatt W. Yue, Nathan R. Rose, et al.. (2011). Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family. Journal of Biological Chemistry. 286(48). 41616–41625. 140 indexed citations
10.
Luo, Xuelai, Yongxiang Liu, Stefan Kubicek, et al.. (2011). A Selective Inhibitor and Probe of the Cellular Functions of Jumonji C Domain-Containing Histone Demethylases. Journal of the American Chemical Society. 133(24). 9451–9456. 121 indexed citations
11.
King, Oliver N. F., Masaaki Sakurai, Akane Kawamura, et al.. (2010). Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors. PLoS ONE. 5(11). e15535–e15535. 173 indexed citations
12.
Rose, Nathan R., Esther C. Y. Woon, Oliver N. F. King, et al.. (2010). Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches. Journal of Medicinal Chemistry. 53(4). 1810–1818. 130 indexed citations
13.
Sakurai, Masaaki, Nathan R. Rose, Lena Schultz, et al.. (2009). A miniaturized screen for inhibitors of Jumonji histonedemethylases. Molecular BioSystems. 6(2). 357–364. 76 indexed citations
14.
Ng, Stanley S., Wyatt W. Yue, Udo Oppermann, & Robert J. Klose. (2008). Dynamic protein methylation in chromatin biology. Cellular and Molecular Life Sciences. 66(3). 407–22. 135 indexed citations
15.
Rose, Nathan R., Stanley S. Ng, Jasmin Mecinović, et al.. (2008). Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases. Journal of Medicinal Chemistry. 51(22). 7053–7056. 199 indexed citations
16.
Kang, Xiaoqiang, Dipa Patel, Stanley S. Ng, & Maxine Melchior. (2007). Enhanced antitumor activity with anti-epidermal growth factor receptor monoclonal antibody cetuximab in combination with carboplatin in preclinical human ovarian carcinoma models. Molecular Cancer Therapeutics. 6. 1 indexed citations
17.
18.
Ng, Stanley S., K.L. Kavanagh, M.A. McDonough, et al.. (2007). Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature. 448(7149). 87–91. 263 indexed citations
19.
Ng, Stanley S., et al.. (2000). Cellular transport processes of aminoguanidine, a nitric oxide synthase inhibitor, in the opossum kidney cell culture line. International Journal of Pharmaceutics. 194(2). 209–220. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise J. Walport Breakdown of academic impact, for papers by Rok Sekirnik Breakdown of academic impact, for papers by Debin Ji Breakdown of academic impact, for papers by Jordi Frigola Breakdown of academic impact, for papers by Herschel Wade Breakdown of academic impact, for papers by Sreenivas Kanugula Breakdown of academic impact, for papers by Ganesh Nagaraju Breakdown of academic impact, for papers by Karina Goodtzova Breakdown of academic impact, for papers by Nobuko Shindo‐Okada Breakdown of academic impact, for papers by Zhifeng Yu
Rankless by CCL
2026